Quantum Genomics/ FR0011648971 /
2024-07-29 4:45:02 PM | Chg. +0.0034 | Volume | Bid4:45:02 PM | Ask5:30:00 PM | High | Low |
---|---|---|---|---|---|---|
0.0985EUR | +3.58% | 17,145 Turnover: 1,676.9920 |
0.0985Bid Size: 19,230 | 0.1010Ask Size: 20 | 0.1036 | 0.0924 |
GlobeNewswire
2021-12-06
Quantum Genomics Signs an Exclusive License and Production Agreement with Gulf Pharmaceuticals Indus...
GlobeNewswire
2021-11-25
Quantum Genomics signs an exclusive license agreement with Teva Israel Ltd.
GlobeNewswire
2021-08-27
Quantum Genomics Presents Results from Phase IIb QUORUM Study of Firibastat in Heart Failure at the ...
GlobeNewswire
2021-07-08
Quantum Genomics Enrolls First Patient in Its Pivotal Phase III REFRESH Trial of Firibastat in Diffi...
GlobeNewswire
2021-07-05
Presentation of the Effects of QGC606 in an Experimental Model of Heart Failure at the Annual Congre...
GlobeNewswire
2021-05-19
Quantum Genomics Announces the Publication of New Scientific Article in Biomedicine & Pharmacotherap...
GlobeNewswire
2021-04-21
Quantum Genomics Will Present Top-line Results From its QUORUM Study of Firibastat in Heart Failure ...
GlobeNewswire
2021-04-20
Quantum Genomics Announces the End of its Collaboration with Qilu for the Development and Commercial...
GlobeNewswire
2021-01-18
Quantum Genomics Launches Phase III Pivotal REFRESH Study in Difficult-to-treat/Resistant Hypertensi...
GlobeNewswire
2020-12-15
Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Faran
GlobeNewswire
2020-12-02
Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with DongWha Pharm
GlobeNewswire
2020-11-02
Quantum Genomics Announces End of Financing Agreement with Negma Group Ltd/Park Partners
GlobeNewswire
2020-10-28
Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Xediton Pharmaceut...
GlobeNewswire
2020-10-19
Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Qilu Pharmaceutica...
GlobeNewswire
2020-09-22
Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Orient EuroPharma ...
GlobeNewswire
2020-07-13
Quantum Genomics Enrolls First Patient in Its Pivotal Phase III FRESH Trial of Firibastat in Difficu...
GlobeNewswire
2020-05-06
Quantum Genomics Announces Interim Analysis from Study of Firibastat in Renal Failure Patients